Biotech
BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 02/27/15 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that Eddie Gray, the Company's Chief Executive Officer, will present at the Cowen and ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 02/27/15 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV) has been made aware of a fraudulent press release disseminat ...
NORWOOD, MA: NORWOOD, MA -- (Marketwired) -- 02/27/15 -- (OTCQB: CRBP) (the "Company"), an emerging drug development company focused on the development and commercialization of its lead product candida ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 02/27/15 -- (NASDAQ: ATOS), the Breast Care Company, announced today that its subsidiary, The National Reference Laboratory for Breast Health (the NRLBH), has received ...
DUBLIN, IRELAND: Fourth Quarter Net Sales of $103.8 Million, Up 245 Percent Year over Year; Full Year Net Sales of $297.0 Million, Up 301 Percent Year over Year; Raises Net Sales and Adjusted EBITDA Guidance for 2015; ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 02/27/15 -- Theratechnologies Inc. (TSX: TH) is pleased to announce that it has concluded an agreement with AOP Orphan Pharmaceuticals AG (AOP) for the distribut ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 02/26/15 -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV), a clinical-stage company focused on commercializing trea ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 02/26/15 -- (NASDAQ: ATOS), the Breast Care Company, announced today that , the U.S. Medical business of Henry Schein, Inc. (NASDAQ: HSIC), will offer its customers th ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 02/26/15 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the year ended November 30, 2014.Fiscal year 2014 fina ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 02/26/15 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") is pleased to advise that Mr. Eutillio ...
SAN FRANCISCO, CA: Fourth Quarter Collaboration Revenue $274.7 Million (+184% vs. Prior Year); Fourth Quarter Net Income $164.2 Million, or $1.96 per Diluted Share; Full Year 2014 Collaboration Revenue $710.5 Million (+ ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 02/25/15 -- Arch Biopartners Inc ("Arch" or the "Company") (TSX VENTURE: ACH)(OTCBB: FOIFF) announced today the U.S. Patent and Trademark Off ...
NEWARK, DE: NEWARK, DE -- (Marketwired) -- 02/25/15 -- iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of US pat ...
PORTLAND, ME: PORTLAND, ME -- (Marketwired) -- 02/25/15 -- (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 02/24/15 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:Rick Bierly, chief financial officer will present at ...
BOSTON, MA: Dr. Barbara Tardiff Joins a Faculty of Clinical Data Authorities to Discuss Advancing Clinical Trials With New Technologies and Existing Data Sources at Clinical Research Informatics World 2015, May 6 ...
SAN DIEGO, CA: Company Sees Recent Pharma Deal as Positive Validation of Its IDO-Targeting Technology ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 02/24/15 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (TSX VENTURE: BMR.H) today announced its fourth quarter and full year 2 ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 02/24/15 -- (NASDAQ: CBLI) today reported financial results and development progress for the fourth quarter and fiscal year ended December 31, 2014.Cleveland BioLabs r ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 02/24/15 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquirin ...